{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:44:55Z","timestamp":1785800695422,"version":"3.56.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ERC-2018-AdG 834860-EYELETS"],"award-info":[{"award-number":["ERC-2018-AdG 834860-EYELETS"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic islet transplantation can restore insulin production in patients with severe diabetes, but donor material is scarce, and early engraftment is constrained by inflammatory and mechanical stress and a prolonged avascular phase, during which oxygen and nutrient delivery are limited by diffusion. Revascularization relies primarily on stress-induced vascular endothelial growth factor A (VEGF-A), prolonging metabolic compromise, increasing autophagic burden, and rendering grafts vulnerable to secondary stress. Accelerating vascular integration during this time window is therefore critical for graft health. We show that \u03b2-cell-targeted aptamer-VEGF-A small activating RNA (saRNA) chimeras selectively induce robust VEGF-A expression in mouse and human islets independently of hypoxia- or nutrient-stress pathways, without activating autophagy or stress-responsive genes. In vivo, chimera-primed islets transplanted into anterior chamber and kidney capsule models exhibited accelerated vascular migration, earlier perfusion, and faster resolution of LC3-dependent autophagic stress without altering endpoint vascular density. Functionally, marginal-mass mouse and human grafts restored glucose control more effectively, preserved intra-islet architecture, and delayed hyperglycemia following STZ-induced \u03b2-cell loss. The RNA chimera\u2019s modular architecture of RNA chimeras allows transient, tissue-adaptable transcriptional activation across species and cell sources. These findings establish that brief, ex vivo RNA-mediated priming preconditions islets to withstand early engraftment stress, enhancing vascular integration and functional outcomes. This scalable, stress-independent strategy may lower the minimum effective transplant mass and expand access to cellular therapies for diabetes.<\/jats:p>","DOI":"10.1038\/s41392-026-02934-8","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:01:21Z","timestamp":1785798081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-cell-targeted RNA activation of vascular endothelial growth factor-A improves islet transplantation"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3457-761X","authenticated-orcid":false,"given":"Dimitri","family":"Van Simaeys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Olof","family":"Berggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2934_CR1","doi-asserted-by":"publisher","first-page":"a007823","DOI":"10.1101\/cshperspect.a007823","volume":"2","author":"M McCall","year":"2012","unstructured":"McCall, M. & James Shapiro, A. M. Update on islet transplantation. Cold Spring Harb. Perspect. Med. 2, a007823 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2934_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(25)00003-8","volume":"13","author":"M Chetboun","year":"2025","unstructured":"Chetboun, M. & Pattou, F. Long-term outcomes and challenges of islet transplantation in type 1 diabetes. Lancet Diabetes Endocrinol. 13, 264\u2013265 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2934_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41574-022-00651-0","volume":"18","author":"C Greenhill","year":"2022","unstructured":"Greenhill, C. Increasing success of islet transplantation. Nat. Rev. Endocrinol. 18, 193\u2013193 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2934_CR4","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","volume":"187","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 187, 6152\u20136164.e18 (2024).","journal-title":"Cell"},{"key":"2934_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","volume":"31","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate. Cell Stem Cell 31, 334\u2013340.e5 (2024).","journal-title":"Cell Stem Cell"},{"key":"2934_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMoa2506549","volume":"393","author":"TW Reichman","year":"2025","unstructured":"Reichman, T. W. et al. Stem cell-derived, fully differentiated islets for type 1 diabetes. N. Engl. J. Med. 393, 858\u2013868 (2025).","journal-title":"N. Engl. J. Med."},{"key":"2934_CR7","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2337\/db08-0814","volume":"57","author":"M Brissova","year":"2008","unstructured":"Brissova, M. & Powers, A. C. Revascularization of transplanted islets can it be improved? Diabetes 57, 2269\u20132271 (2008).","journal-title":"Diabetes"},{"key":"2934_CR8","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.2337\/db06-0690","volume":"55","author":"M Brissova","year":"2006","unstructured":"Brissova, M. et al. Pancreatic islet production of vascular endothelial growth factor-A is essential for islet vascularization, revascularization, and function. Diabetes 55, 2974\u20132985 (2006).","journal-title":"Diabetes"},{"key":"2934_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/ajt.12558","volume":"14","author":"B Naziruddin","year":"2014","unstructured":"Naziruddin, B. et al. Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. Am. J. Transplant. 14, 428\u2013437 (2014).","journal-title":"Am. J. Transplant."},{"key":"2934_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14623","volume":"5","author":"GA Paredes-Juarez","year":"2015","unstructured":"Paredes-Juarez, G. A. et al. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci. Rep. 5, 1\u201312 (2015).","journal-title":"Sci. Rep."},{"key":"2934_CR11","doi-asserted-by":"crossref","unstructured":"Cayabyab, F., Nih, L. R. & Yoshihara, E. Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front. Endocrinol. 12, 732431 (2021).","DOI":"10.3389\/fendo.2021.732431"},{"key":"2934_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/1932296819868495","volume":"14","author":"P Addison","year":"2019","unstructured":"Addison, P., Fatakhova, K. & Rodriguez Rilo, H. L. Considerations for an alternative site of islet cell transplantation. J. Diabetes Sci. Technol. 14, 338 (2019).","journal-title":"J. Diabetes Sci. Technol."},{"key":"2934_CR13","doi-asserted-by":"crossref","unstructured":"Figueiredo, H. et al. Targeting pancreatic islet PTP1B improves islet graft revascularization and transplant outcomes. Sci. Transl. Med. 11, eaar6294 (2019).","DOI":"10.1126\/scitranslmed.aar6294"},{"key":"2934_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-011-2091-y","volume":"54","author":"VL Perez","year":"2011","unstructured":"Perez, V. L. et al. The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia 54, 1121\u20131126 (2011).","journal-title":"Diabetologia"},{"key":"2934_CR15","first-page":"5592","volume":"58","author":"N Gerber-Hollbach","year":"2017","unstructured":"Gerber-Hollbach, N. et al. First-in-man pancreatic islet transplantation in the anterior chamber of the human eye. Investig. Ophthalmol. Vis. Sci. 58, 5592\u20135592 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"2934_CR16","unstructured":"Midhat H. Abdulreda, U. of M. (Responsible P. Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye. Clinicaltrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02846571 (2019)."},{"key":"2934_CR17","doi-asserted-by":"crossref","unstructured":"Ogle, G. D. et al. Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res. Clin. Pract. 225, 112277 (2025).","DOI":"10.1016\/j.diabres.2025.112277"},{"key":"2934_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1600-6143.2008.02234.x","volume":"8","author":"A Gangemi","year":"2008","unstructured":"Gangemi, A. et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am. J. Transplant. 8, 1250\u20131261 (2008).","journal-title":"Am. J. Transplant."},{"key":"2934_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","volume":"39","author":"BJ Hering","year":"2016","unstructured":"Hering, B. J. et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39, 1230\u20131240 (2016).","journal-title":"Diabetes Care"},{"key":"2934_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-023-01089-8","volume":"15","author":"M Mantovani","year":"2023","unstructured":"Mantovani, M. et al. Islet transplantation: overcoming the organ shortage. Diabetol. Metab. Syndr. 15, 1\u20138 (2023).","journal-title":"Diabetol. Metab. Syndr."},{"key":"2934_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep09322","volume":"5","author":"E Hajizadeh-Saffar","year":"2015","unstructured":"Hajizadeh-Saffar, E. et al. Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. Sci. Rep. 5, 9322 (2015).","journal-title":"Sci. Rep."},{"key":"2934_CR22","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.2337\/diabetes.47.12.1894","volume":"47","author":"B Vasir","year":"1998","unstructured":"Vasir, B. et al. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 47, 1894\u20131903 (1998).","journal-title":"Diabetes"},{"key":"2934_CR23","doi-asserted-by":"publisher","first-page":"27664","DOI":"10.1074\/jbc.M109.041616","volume":"284","author":"K Fujimoto","year":"2009","unstructured":"Fujimoto, K. et al. Autophagy regulates pancreatic beta cell death in response to PDX1 deficiency and nutrient deprivation. J. Biol. Chem. 284, 27664 (2009).","journal-title":"J. Biol. Chem."},{"key":"2934_CR24","first-page":"237","volume":"5","author":"S Pugazhenthi","year":"2015","unstructured":"Pugazhenthi, S. Pancreatic beta cell autophagy and islet transplantation. Autophagy Cancer Other Pathol. Inflamm. Immunity Infect. Aging 5, 237\u2013247 (2015).","journal-title":"Autophagy Cancer Other Pathol. Inflamm. Immunity Infect. Aging"},{"key":"2934_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","volume":"65","author":"G Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s, G. & Pouyss\u00e9gur, J. Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc. Res. 65, 564\u2013573 (2005).","journal-title":"Cardiovasc. Res."},{"key":"2934_CR26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.jmb.2019.07.030","volume":"432","author":"K Vivot","year":"2020","unstructured":"Vivot, K., Pasquier, A., Goginashvili, A. & Ricci, R. Breaking bad and breaking good: \u03b2-cell autophagy pathways in diabetes. J. Mol. Biol. 432, 1494\u20131513 (2020).","journal-title":"J. Mol. Biol."},{"key":"2934_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1126\/science.aaa2628","volume":"347","author":"A Goginashvili","year":"2015","unstructured":"Goginashvili, A. et al. Insulin secretory granules control autophagy in Pancreatic \u03b2 cells. Science 347, 878\u2013882 (2015).","journal-title":"Science"},{"key":"2934_CR28","doi-asserted-by":"crossref","unstructured":"Mohammadi-Motlagh, H. R. et al. \u03b2 Cell and autophagy: what do we know? Biomolecules 13, 649 (2023).","DOI":"10.3390\/biom13040649"},{"key":"2934_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.gt.3302267","volume":"11","author":"K Cheng","year":"2004","unstructured":"Cheng, K. et al. Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets. Gene Ther. 11, 1105\u20131116 (2004).","journal-title":"Gene Ther."},{"key":"2934_CR30","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00125-010-1745-5","volume":"53","author":"M Shimoda","year":"2010","unstructured":"Shimoda, M., Chen, S., Noguchi, H., Matsumoto, S. & Grayburn, P. A. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia 53, 1669 (2010).","journal-title":"Diabetologia"},{"key":"2934_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/emm.2005.64","volume":"37","author":"HY Chae","year":"2005","unstructured":"Chae, H. Y. et al. Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice. Exp. Mol. Med. 37, 513\u2013523 (2005).","journal-title":"Exp. Mol. Med."},{"key":"2934_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/stem.2823","volume":"36","author":"Y He","year":"2018","unstructured":"He, Y. et al. Bone marrow-derived mesenchymal stem cells protect islet grafts against endoplasmic reticulum stress-induced apoptosis during the early stage after transplantation. Stem Cells 36, 1045\u20131061 (2018).","journal-title":"Stem Cells"},{"key":"2934_CR33","doi-asserted-by":"crossref","unstructured":"Weaver, J. D. et al. Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Sci. Adv. 3, e1700184 (2017).","DOI":"10.1126\/sciadv.1700184"},{"key":"2934_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13346-013-0142-2","volume":"5","author":"EA Phelps","year":"2015","unstructured":"Phelps, E. A., Templeman, K. L., Thul\u00e9, P. M. & Garc\u00eda, A. J. Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization. Drug Deliv. Transl. Res. 5, 125 (2015).","journal-title":"Drug Deliv. Transl. Res."},{"key":"2934_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ydbio.2012.04.022","volume":"367","author":"Q Cai","year":"2012","unstructured":"Cai, Q. et al. Enhanced expression of VEGF-A in \u03b2 cells increases endothelial cell number but impairs islet morphogenesis and \u03b2 cell proliferation. Dev. Biol. 367, 40\u201354 (2012).","journal-title":"Dev. Biol."},{"key":"2934_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6 mRNA-based therapeutics\u2014developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759\u2013780 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2934_CR37","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s00125-018-4646-7","volume":"61","author":"W Staels","year":"2018","unstructured":"Staels, W. et al. Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation. Diabetologia 61, 1804\u20131810 (2018).","journal-title":"Diabetologia"},{"key":"2934_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","volume":"21","author":"A Coll\u00e9n","year":"2021","unstructured":"Coll\u00e9n, A. et al. VEGFA mRNA for regenerative treatment of heart failure. Nat. Rev. Drug Discov. 21, 79\u201380 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2934_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08852-4","volume":"10","author":"LM Gan","year":"2019","unstructured":"Gan, L. M. et al. Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nat. Commun. 10, 1\u20139 (2019).","journal-title":"Nat. Commun."},{"key":"2934_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","volume":"31","author":"V Anttila","year":"2023","unstructured":"Anttila, V. et al. Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting. Mol. Ther. 31, 866\u2013874 (2023).","journal-title":"Mol. Ther."},{"key":"2934_CR41","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","volume":"403","author":"H Parhiz","year":"2024","unstructured":"Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. mRNA-based therapeutics: looking beyond COVID-19 vaccines. Lancet 403, 1192\u20131204 (2024).","journal-title":"Lancet"},{"key":"2934_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41580-021-00356-8","volume":"22","author":"S Das","year":"2021","unstructured":"Das, S., Vera, M., Gandin, V., Singer, R. H. & Tutucci, E. Intracellular mRNA transport and localized translation. Nat. Rev. Mol. Cell Biol. 22, 483\u2013504 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2934_CR43","doi-asserted-by":"publisher","first-page":"e2307798120","DOI":"10.1073\/pnas.2307798120","volume":"121","author":"J Witten","year":"2024","unstructured":"Witten, J., Hu, Y., Langer, R. & Anderson, D. G. Recent advances in nanoparticulate RNA delivery systems. Proc. Natl. Acad. Sci. USA 121, e2307798120 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2934_CR44","doi-asserted-by":"publisher","first-page":"17337","DOI":"10.1073\/pnas.0607015103","volume":"103","author":"L-C Li","year":"2006","unstructured":"Li, L.-C. et al. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. USA 103, 17337\u201317342 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2934_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cells10030591","volume":"10","author":"H Ghanbarian","year":"2021","unstructured":"Ghanbarian, H. et al. Small activating RNAs: towards the development of new therapeutic agents and clinical treatments. Cells 10, 591 (2021).","journal-title":"Cells"},{"key":"2934_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/cr.2016.22","volume":"26","author":"V Portnoy","year":"2016","unstructured":"Portnoy, V. et al. saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription. Cell Res. 26, 320\u2013335 (2016).","journal-title":"Cell Res."},{"key":"2934_CR47","doi-asserted-by":"crossref","unstructured":"Turunen, M. P. et al. Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice. PLoS One 9, e89979 (2014).","DOI":"10.1371\/journal.pone.0089979"},{"key":"2934_CR48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"JO McNamara","year":"2006","unstructured":"McNamara, J. O. et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005\u20131015 (2006).","journal-title":"Nat. Biotechnol."},{"key":"2934_CR49","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/mt.2016.60","volume":"24","author":"S Yoon","year":"2016","unstructured":"Yoon, S. et al. Targeted delivery of C\/EBP\u03b1 -saRNA by pancreatic ductal adenocarcinoma-specific RNA aptamers inhibits tumor growth in vivo. Mol. Ther. 24, 1106\u20131116 (2016).","journal-title":"Mol. Ther."},{"key":"2934_CR50","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1021\/jacs.3c00841","volume":"145","author":"S Xie","year":"2023","unstructured":"Xie, S. et al. Aptamer-based targeted delivery of functional nucleic acids. J. Am. Chem. Soc. 145, 7677\u20137691 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2934_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-29377-3","volume":"13","author":"D Van Simaeys","year":"2022","unstructured":"Van Simaeys, D. et al. RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human \u03b2 cells. Nat. Commun. 13, 1\u201318 (2022).","journal-title":"Nat. Commun."},{"key":"2934_CR52","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCRESAHA.109.200774","volume":"105","author":"MP Turunen","year":"2009","unstructured":"Turunen, M. P. et al. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ. Res. 105, 604\u2013609 (2009).","journal-title":"Circ. Res."},{"key":"2934_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jcb.25283","volume":"117","author":"S Chen","year":"2016","unstructured":"Chen, S. & Sang, N. Hypoxia-Inducible Factor-1: a critical player in the survival strategy of stressed cells. J. Cell. Biochem. 117, 267 (2016).","journal-title":"J. Cell. Biochem."},{"key":"2934_CR54","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Mari\u00f1o, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280\u2013293 (2010).","journal-title":"Mol. Cell"},{"key":"2934_CR55","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/antiox11091747","volume":"11","author":"Y Hu","year":"2022","unstructured":"Hu, Y., Luo, Y. & Zheng, Y. Nrf2 pathway and autophagy crosstalk: new insights into therapeutic strategies for ischemic cerebral vascular diseases. Antioxidants 11, 1747 (2022).","journal-title":"Antioxidants"},{"key":"2934_CR56","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1091\/mbc.e04-05-0374","volume":"15","author":"N Pore","year":"2004","unstructured":"Pore, N. et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 15, 4841\u20134853 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"2934_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/092986712803413944","volume":"19","author":"A Ahluwalia","year":"2012","unstructured":"Ahluwalia, A. & Tarnawski, A. S. Critical role of hypoxia sensor - HIF-1\u03b1 in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem. 19, 90\u201397 (2012).","journal-title":"Curr. Med. Chem."},{"key":"2934_CR58","doi-asserted-by":"publisher","first-page":"115463","DOI":"10.1016\/j.biopha.2023.115463","volume":"167","author":"B Wei","year":"2023","unstructured":"Wei, B., Zhang, X., Qian, J., Tang, Z. & Zhang, B. Nrf2: Therapeutic target of islet function protection in diabetes and islet transplantation. Biomed. Pharmacother. 167, 115463 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2934_CR59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/ASN.2013040374","volume":"25","author":"L Li","year":"2014","unstructured":"Li, L., Wang, Z. V., Hill, J. A. & Lin, F. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J. Am. Soc. Nephrol. 25, 305\u2013315 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2934_CR60","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1177\/0963689718801006","volume":"27","author":"E Estilles","year":"2018","unstructured":"Estilles, E., T\u00e9llez, N., Nacher, M. & Montanya, E. A model for human islet transplantation to immunodeficient streptozotocin-induced diabetic mice. Cell Transplant 27, 1684\u20131691 (2018).","journal-title":"Cell Transplant"},{"key":"2934_CR61","doi-asserted-by":"crossref","unstructured":"Velazco-Cruz, L., Goedegebuure, M. M. & Millman, J. R. Advances toward engineering functionally mature human pluripotent stem cell-derived \u03b2 cells. Front. Bioeng. Biotechnol. 8, 786 (2020).","DOI":"10.3389\/fbioe.2020.00786"},{"key":"2934_CR62","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.stemcr.2017.07.012","volume":"9","author":"G Faleo","year":"2017","unstructured":"Faleo, G. et al. Mitigating ischemic injury of stem cell-derived insulin-producing cells after transplant. Stem Cell Rep. 9, 807\u2013819 (2017).","journal-title":"Stem Cell Rep."},{"key":"2934_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2026.102892","volume":"21","author":"S Wu","year":"2026","unstructured":"Wu, S. et al. An optimized protocol for efficient derivation of pancreatic islets from multiple human pluripotent stem cell lines. Stem Cell Rep. 21, 102892 (2026).","journal-title":"Stem Cell Rep."},{"key":"2934_CR64","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/wrna.90","volume":"2","author":"V Portnoy","year":"2011","unstructured":"Portnoy, V., Huang, V., Place, R. F. & Li, L.-C. Small RNA and transcriptional upregulation. Wiley Interdiscip. Rev. RNA 2, 748\u2013760 (2011).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"2934_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s44222-024-00238-6","volume":"3","author":"SS Liu","year":"2024","unstructured":"Liu, S. S. et al. Encapsulated islet transplantation. Nat. Rev. Bioeng. 3, 83\u2013102 (2024).","journal-title":"Nat. Rev. Bioeng."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02934-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:01:23Z","timestamp":1785798083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02934-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2934"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02934-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.-O.B. serves on the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of handling the manuscript. D.V.S. has no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"318"}}